MiMedx Group, Inc. Contract Liability (Deferred Revenue)
MiMedx Group, Inc. (MDXG) had Contract Liability (Deferred Revenue) of $559.00 thousand as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2022-02-28
- 2021-12-31: Contract with Customer, Liability, Current $559.00K.
- 2021-09-30: Contract with Customer, Liability, Current $496.00K.
- 2021-06-30: Contract with Customer, Liability, Current $520.00K.
- 2020-12-31: Contract with Customer, Liability, Current $554.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2021-12-31 | $559.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $496.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $520.00K 10-Q · filed 2021-08-03 |
| 2020-12-31 | $554.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |